| __timestamp | Viking Therapeutics, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 22223073 | 15411924 |
| Thursday, January 1, 2015 | 6966842 | 22593274 |
| Friday, January 1, 2016 | 9000499 | 33173050 |
| Sunday, January 1, 2017 | 13741186 | 62224159 |
| Monday, January 1, 2018 | 19040000 | 95607434 |
| Tuesday, January 1, 2019 | 23559000 | 221269028 |
| Wednesday, January 1, 2020 | 31931000 | 400745069 |
| Friday, January 1, 2021 | 44981000 | 580520000 |
| Saturday, January 1, 2022 | 54234000 | 663366000 |
| Sunday, January 1, 2023 | 63806000 | 755113687 |
Cracking the code
In the competitive world of biotechnology, innovation is the lifeblood of success. Argenx SE and Viking Therapeutics, Inc. are two companies that exemplify this drive. Over the past decade, Argenx SE has consistently outpaced Viking Therapeutics in research and development (R&D) spending, a key indicator of innovation. From 2014 to 2023, Argenx SE increased its R&D expenses by nearly 4,800%, reaching a peak in 2023. In contrast, Viking Therapeutics saw a more modest increase of approximately 187% over the same period.
This significant difference highlights Argenx SE's aggressive strategy to lead in the biotech sector. By 2023, Argenx SE's R&D investment was over 11 times that of Viking Therapeutics. This commitment to innovation positions Argenx SE as a formidable player in the industry, potentially leading to groundbreaking advancements and a stronger market presence.
Regeneron Pharmaceuticals, Inc. or argenx SE: Who Invests More in Innovation?
argenx SE or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for argenx SE and Ultragenyx Pharmaceutical Inc.
Research and Development Investment: argenx SE vs BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Viking Therapeutics, Inc.
Analyzing R&D Budgets: Genmab A/S vs Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for BioMarin Pharmaceutical Inc. and Viking Therapeutics, Inc.
Blueprint Medicines Corporation vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.